121 related articles for article (PubMed ID: 8629814)
1. Herpes simplex type1:lacZ recombinant viruses. II. Microtiter plate-based colorimetric assays for the discovery of new antiherpes agents and the points at which such agents disrupt the viral replication cycle.
Dicker IB; Blasecki JW; Seetharam S
Antiviral Res; 1995 Nov; 28(3):213-24. PubMed ID: 8629814
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex type 1:lacZ recombinant viruses. I. Characterization and application to defining the mechanisms of action of known antiherpes agents.
Dicker IB; Seetharam S
Antiviral Res; 1995 Nov; 28(3):191-212. PubMed ID: 8629813
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells.
Faith SA; Sweet TJ; Bailey E; Booth T; Docherty JJ
Antiviral Res; 2006 Dec; 72(3):242-51. PubMed ID: 16876885
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
5. Samarangenin B from Limonium sinense suppresses herpes simplex virus type 1 replication in Vero cells by regulation of viral macromolecular synthesis.
Kuo YC; Lin LC; Tsai WJ; Chou CJ; Kung SH; Ho YH
Antimicrob Agents Chemother; 2002 Sep; 46(9):2854-64. PubMed ID: 12183238
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of PHA767491 against human herpes simplex virus in vitro and in vivo.
Hou J; Zhang Z; Huang Q; Yan J; Zhang X; Yu X; Tan G; Zheng C; Xu F; He S
BMC Infect Dis; 2017 Mar; 17(1):217. PubMed ID: 28320320
[TBL] [Abstract][Full Text] [Related]
7. Replication-Competent Controlled Herpes Simplex Virus.
Bloom DC; Feller J; McAnany P; Vilaboa N; Voellmy R
J Virol; 2015 Oct; 89(20):10668-79. PubMed ID: 26269179
[TBL] [Abstract][Full Text] [Related]
8. Binding of ICP4, TATA-binding protein, and RNA polymerase II to herpes simplex virus type 1 immediate-early, early, and late promoters in virus-infected cells.
Sampath P; Deluca NA
J Virol; 2008 Mar; 82(5):2339-49. PubMed ID: 18094162
[TBL] [Abstract][Full Text] [Related]
9. The role of ICP4 repressor activity in temporal expression of the IE-3 and latency-associated transcript promoters during HSV-1 infection.
Rivera-Gonzalez R; Imbalzano AN; Gu B; Deluca NA
Virology; 1994 Aug; 202(2):550-64. PubMed ID: 8030221
[TBL] [Abstract][Full Text] [Related]
10. Antiviral Properties of the LSD1 Inhibitor SP-2509.
Harancher MR; Packard JE; Cowan SP; DeLuca NA; Dembowski JA
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699090
[TBL] [Abstract][Full Text] [Related]
11. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro.
Bourinbaiar AS; Coleman CF
Arch Virol; 1997; 142(11):2225-35. PubMed ID: 9672588
[TBL] [Abstract][Full Text] [Related]
12. Yatein from Chamaecyparis obtusa suppresses herpes simplex virus type 1 replication in HeLa cells by interruption the immediate-early gene expression.
Kuo YC; Kuo YH; Lin YL; Tsai WJ
Antiviral Res; 2006 Jul; 70(3):112-20. PubMed ID: 16540181
[TBL] [Abstract][Full Text] [Related]
13. Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression.
Decman V; Kinchington PR; Harvey SA; Hendricks RL
J Virol; 2005 Aug; 79(16):10339-47. PubMed ID: 16051826
[TBL] [Abstract][Full Text] [Related]
14. Binding sites for the herpes simplex virus immediate-early protein ICP4 impose an increased dependence on viral DNA replication on simple model promoters located in the viral genome.
Koop KE; Duncan J; Smiley JR
J Virol; 1993 Dec; 67(12):7254-63. PubMed ID: 8230448
[TBL] [Abstract][Full Text] [Related]
15. A point mutation within conserved region VI of herpes simplex virus type 1 DNA polymerase confers altered drug sensitivity and enhances replication fidelity.
Hwang YT; Zuccola HJ; Lu Q; Hwang CB
J Virol; 2004 Jan; 78(2):650-7. PubMed ID: 14694096
[TBL] [Abstract][Full Text] [Related]
16. Regulation of herpes simplex virus 1 replication using tumor-associated promoters.
Mullen JT; Kasuya H; Yoon SS; Carroll NM; Pawlik TM; Chandrasekhar S; Nakamura H; Donahue JM; Tanabe KK
Ann Surg; 2002 Oct; 236(4):502-12; discussion 512-3. PubMed ID: 12368679
[TBL] [Abstract][Full Text] [Related]
17. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
[TBL] [Abstract][Full Text] [Related]
18. β-Carboline derivatives as novel antivirals for herpes simplex virus.
Gonzalez MM; Cabrerizo FM; Baiker A; Erra-Balsells R; Osterman A; Nitschko H; Vizoso-Pinto MG
Int J Antimicrob Agents; 2018 Oct; 52(4):459-468. PubMed ID: 30006037
[TBL] [Abstract][Full Text] [Related]
19. Curcumin inhibits herpes simplex virus immediate-early gene expression by a mechanism independent of p300/CBP histone acetyltransferase activity.
Kutluay SB; Doroghazi J; Roemer ME; Triezenberg SJ
Virology; 2008 Apr; 373(2):239-47. PubMed ID: 18191976
[TBL] [Abstract][Full Text] [Related]
20. Long-term transgene expression in mice infected with a herpes simplex virus type 1 mutant severely impaired for immediate-early gene expression.
Marshall KR; Lachmann RH; Efstathiou S; Rinaldi A; Preston CM
J Virol; 2000 Jan; 74(2):956-64. PubMed ID: 10623758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
